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Background: Low-dose reactive wheat-allergic children are at a high risk of a positive oral food challenge
(OFC). The present study aimed to evaluate whether the results of a very low-dose (VL) OFC would
contribute to better wheat allergy management in this population.
Methods: We retrospectively reviewed wheat-allergic subjects who underwent a VL OFC with 2 g of
udon noodles (equivalent to 53 mg of wheat protein) and had a previous allergic reaction to <15 g of
udon noodles (equivalent to 400 mg of wheat protein) within 2 years before the OFC. Subjects who
passed the OFC were deﬁned as VL tolerant; those who failed were considered VL reactive. In VL tolerant
subjects, the dose was increased to 15 g of udon noodles either during an OFC in our hospital or gradually
at home.
Results: Of the 57 included subjects (median age, 2.9 years; range, 1.0e11.8 years), 32 (56%) were VL
tolerant and 25 (44%) were VL reactive. Most reactions during the OFC could be treated with an anti-
histamine and/or a nebulized b2 agonist. VL tolerant subjects consumed 2 g of udon noodles or a
seasoning containing wheat. Within a year after the OFC, 18 VL tolerant subjects (56%), but no VL reactive
subjects, were able to consume 15 g of udon noodles (p < 0.001).
Conclusions: AVL OFC can shift the management of some low-dose reactive wheat-allergic children from
complete avoidance to partial wheat intake.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Immunoglobulin (Ig) E-mediated wheat allergy is the third-
most common food allergy in Japan.1 A review of the natural his-
tory of wheat allergy reported that 29%, 56%, and 65% of children
outgrow such allergies by age 4, 8, and 12 years, respectively.2,3
However, many children continue to suffer from wheat allergy,
and an oral food challenge (OFC) is therefore needed to assess the
achievement of tolerance.4 These challenges must be conducted
carefully in low-dose reactive wheat-allergic children, who are at a
high risk of a positive OFC and react severely to high-dose
intakes.5,6
Oral immunotherapy (OIT), which reportedly contributes to
desensitization or threshold elevation in wheat-allergic children,7,8Clinical Research Centre for
al Hospital, 18-1 Sakuradai,
pan.
(M. Ebisawa).
ety of Allergology.
rgology. Production and hosting by Elseis a possible approach for the management of wheat allergy.
However, this process might be impractical or inconvenient in real
life because of the need for daily ingestion and risk of possible
adverse reactions.9
Baked egg and baked milk have been used as approaches for the
management of hen egg allergy and cow's milk allergy, respec-
tively.10,11 On the other hand, wheat is usually consumed in a
cooked form, and allergenicity was not found to differ signiﬁcantly
between raw and cooked forms of wheat.12
We previously reported that a very low-dose (VL) OFC with
cow's milk provided better management in patients with low-
dose reactive cow's milk allergy.13 Therefore, we decided to test
a VL OFC with wheat for wheat allergy. To determine whether a
VL OFC with wheat was as effective for wheat allergy as a VL OFC
with cow's milk for cow's milk allergy, we performed a VL OFC
(2 g of udon noodles, equivalent to 53 mg of wheat protein) and
wheat dose progression in wheat-allergic children who had
experienced a previous reaction to <15 g of udon noodles
(equivalent to 400 mg of wheat protein) based on our daily
practice.vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Study design
We retrospectively reviewed subjects with low-dose wheat re-
actions who underwent a VL OFC involving 2 g of udon noodles.
Subjects who passed the VL OFC were deﬁned as VL tolerant, and
those who failed the VL OFC were deﬁned as VL reactive.
The results of the VL OFC are presented as the OFC positive rate,
as well as symptoms and treatments administered during the OFC.
The results of the wheat dose progression in our daily practice
during a 1-year period after the OFC were compared between the
VL tolerant and VL reactive subjects according to the time needed to
reach an intake of 15 g of udon noodles.
Informed consent for the OFC and data publicationwas obtained
from the children's guardians. This study was approved by the
Sagamihara National Hospital Ethics Committee and was con-
ducted in accordance with the Declaration of Helsinki. The research
plan was posted at Sagamihara National Hospital. However,
because this study was retrospective, registration in an interna-
tionally certiﬁed registry was not required.
Subject selection
The eligible subjects were children who underwent VL OFC
between July 2012 and January 2014, had a previous allergic reac-
tion to <15 g of udon noodles within the 2 years before the VL OFC
(median, 9.3 months; range, 1.5e23.2 months), and had a positive
wheat-speciﬁc IgE test result. Previous allergic reactions were
deﬁned as immediate reactions if they occurred within 2 h after
ingesting wheat. Worsening of eczema or asthma after ingesting
wheat was not included in the immediate reactions. If previous
allergic reactions occurred because of accidental ingestion, wheat
doses were calculated using a conversion table constructed by the
research dieticians.
Assessment of baseline characteristics
The attending physician was responsible for diagnoses of food
allergies, eczema, asthma, and allergic rhino-conjunctivitis.
Anaphylaxis was deﬁned according to the criteria proposed by Si-
mons et al.14
Laboratory testing
For all subjects, wheat-speciﬁc IgE levels were assessed using
the ImmunoCAP assay system (Thermo Fisher Scientiﬁc, Uppsala,
Sweden), and a level >0.35 kilounits of allergen-speciﬁc IgE (kUA)/L
was considered positive. The median time between the laboratory
test and VL OFC was 3.2 months (range, 0.0e18.4 months).
Oral food challenge protocol
The challenge food used in the VL OFC was 2 g of udon noodles
(equivalent to 53 mg of wheat protein). Udon noodles are a tradi-
tional Japanese food prepared by boiling a mixture of wheat ﬂour,
water, and salt for 1 min.
OFCs were performed openly under physician observation at
Sagamihara National Hospital. One quarter of the VL OFC challenge
food was administered initially, and the remaining three quarters
were administered 60 min later. The OFC was concluded when a
quantity of wheat sufﬁcient to cause moderate or severe symptoms
(generalized urticaria, continuous coughing, moderate or severe
abdominal pain, vomiting, or diarrhoea) had been consumed. Ifmild
objective symptoms (localized urticaria or intermittent coughing)appeared during the OFC, the subject was carefully monitored to
detect any worsening of symptoms. If the mild objective symptoms
disappeared within 30 min, the OFC was continued. When an
adverse reaction occurred, treatment (antihistamine, nebulized b2
agonist, steroids, or adrenaline) was administered based on the
EuropeanAcademyofAllergyandClinical Immunology (EAACI) food
allergy and anaphylaxis guidelines.15
Wheat dose progression and follow-up
Subjects who passed the VL OFC were advised to consume 2 g of
udon noodles or a seasoning containing wheat at least once weekly
while at home. One to 3 months after passing the OFC, the wheat
dose was increased to 15 g of udon noodles either during an OFC at
our hospital or gradually at home.With the latter method, the udon
noodle dose was increased by 1 g every few ingestions. If adverse
reactions appeared, the previous dose was repeated. When the
previous dose was passed, the scheduled increase was attempted.
Subjects who failed the VL OFC underwent a second OFC at least 6
months after the ﬁrst OFC.
We prescribed antihistamines for all subjects, adrenaline auto-
injectors for subjects with a history of anaphylaxis, and other
medications depending on complications. All subjects received
instructions on when and how to administer emergency medica-
tions and visit the emergency department.
Statistical analysis
Characteristics at the time of the VL OFC were compared be-
tween the VL tolerant and VL reactive subjects, as well as between
VL tolerant subjects who achieved a dose of 15 g of udon noodles
(15 g tolerant) and VL tolerant subjects who failed an OFC with 15 g
of udon noodles (15 g reactive) within 1 year after the VL OFC using
the ManneWhitney test for continuous variables (expressed as
medians and ranges) and the chi-square or Fisher's exact test for
categorical variables (expressed as numbers and percentages).
Wheat dose progression was measured as the time required to
reach the consumption of 15 g of udon noodles. KaplaneMeier
curveswere generated to depict changes among the VL tolerant and
VL reactive subjects. Differences were estimated using the log-rank
test.
SPSS version 20 (IBM Corp, Armonk, NY, USA) was used for all
analyses.
Results
Baseline subject characteristics
Of the 83 subjectswho underwent the VL OFC between July 2012
and January 2014, 23 subjects were excluded for a previous allergic
reaction towheatmore than 2 years prior, and 3were excluded for a
previous reaction to >15 g of udon noodles within the previous 2
years; a total of 57 subjects (median age, 2.9 years; range, 1.0e11.8
years) remained in the analyses (Fig. 1). The median wheat-speciﬁc
IgE level was 26.9 kUA/L (range, 0.63e1520 kUA/L), and the median
u5-speciﬁc IgE level was 1.5 kUA/L (range, <0.10e65.3 kUA/L)
(Table 1). Of the baseline subject characteristics, the VL tolerant
(n ¼ 32, 56%) and VL reactive (n ¼ 25, 44%) subjects differed
signiﬁcantlywith regard toahistoryof anaphylaxis towheat,wheat-
speciﬁc IgE levels, and u5-speciﬁc IgE levels (Table 1).
The subjects' previous allergic reactions had been caused by
accidental ingestion (56%) or an OFC with wheat (44%). The median
threshold dose at the previous OFC with wheat was 8.0 g (range,
2.0e15.0 g) of udon noodles (Table 2). The threshold dose in the
previous OFC with wheat was higher among VL tolerant subjects
83 subjects underwent VL OFC between July 2012 and January 2014
57 subjects underwent the VL OFC
Previous allergic reaction to <15 g of udon noodles within the previous 2 years
26 subjects were excluded
Previous allergic reaction to wheat >2 years earlier
Previous allergic reaction to >15 g of udon noodles within the previous 2 years
32 subjects passed the VL OFC
VL tolerant
25 subjects failed the VL OFC
VL reactive
Fig. 1. Flowchart of enrolled subjects in an assessment of the usefulness of an oral food challenge (OFC) for wheat allergies. The very low-dose (VL) OFC was conducted with 2 g of
udon noodles (equivalent to 53 mg of wheat protein). In this study, 15 g of udon noodles were considered equivalent to 400 mg of wheat protein.
Table 1
Baseline characteristics of subjects with wheat allergies who underwent a very low-dose oral food challenge.
Characteristic All subjects (n ¼ 57) VL tolerant (n ¼ 32) VL reactive (n ¼ 25) p value*
Age (years) 2.9 (1.0e11.8) 2.0 (1.0e11.8) 3.8 (1.3e6.8) 0.150
Male sex 35 (61) 20 (63) 15 (60) 0.847
History of anaphylaxis to wheat 26 (46) 10 (31) 16 (64) 0.014
Other food allergy, current 48 (84) 25 (78) 23 (92) 0.145
Eczema, current 36 (63) 23 (72) 13 (52) 0.123
Asthma, current 18 (32) 8 (25) 10 (40) 0.227
Allergic rhino-conjunctivitis, current 7 (12) 3 (9.4) 4 (16) 0.360
Total IgE (kUA/L) 448 (45.6e5510) 432 (45.6e3050) 490 (53.1e5510) 0.817
Wheat-speciﬁc IgE (kUA/L) 26.9 (0.63e1520) 15.0 (0.63e72.1) 42.2 (7.5e1520) <0.001
u5-speciﬁc IgE (kUA/L) 1.5 (<0.10e65.3) 0.81 (<0.10e11.9) 5.8 (0.15e65.3) <0.001
*Comparisons between VL tolerant and VL reactive subjects were conducted using the ManneWhitney test for continuous variables or the chi-square or Fisher's exact test for
categorical variables. Statistically signiﬁcant p values (<0.05) are in bold.
Values are reported as medians (ranges) or n (%).
VL, very low dose; IgE, immunoglobulin E; kUA/L, kilounits of allergen-speciﬁc IgE.
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symptoms and anaphylaxis were lower among VL tolerant subjects
than among VL reactive subjects (Table 2).Results of the very low-dose oral food challenge
Respiratory symptoms were most common, occurring in 92%
(n ¼ 23) of the VL reactive subjects, followed by skin symptoms in
72% (n ¼ 18) of the VL reactive subjects. The majority of reactions
were treated with antihistamines and/or nebulized b2 agonists.
Among the 23 subjects with respiratory symptoms, 16 (70%)Table 2
Characteristics of previous allergic reactions to wheat.
Characteristic All subjects (n ¼
Reason for previous allergic reaction to wheat
Accidental ingestion 32 (56)
OFC with wheat 25 (44)
Threshold dose at previous OFC with wheat (g udon noodles) 8.0 (2.0e15.0)
(n ¼ 25)
Symptom during previous allergic reaction to wheat
Skin 51 (90)
Gastrointestinal 9 (16)
Respiratory 30 (53)
Cardiovascular 2 (3.5)
Anaphylaxis 26 (46)
*Comparisons between VL tolerant and VL reactive subjects were conducted using the Ma
categorical variables. Statistically signiﬁcant p values (<0.05) are in bold.
Values are reported as medians (ranges) or n (%).
VL, very low dose; OFC, oral food challenge.
One gram of udon noodles is equivalent to 26.5 mg of wheat protein.received 1 dose of a nebulized b2 agonist, 4 (17%) received 2 doses
of a nebulized b2 agonist, and 3 (13%) received 1 dose of adrenaline.
The subject who received 1 dose of adrenaline for respiratory
symptoms required another dose of adrenaline for mild hypoten-
sion (Table 3).Wheat dose progression based on our daily practice within the year
after the very low-dose oral food challenge
Of the VL tolerant subjects, 17 of 23 who underwent an OFCwith
15 g of udon noodles passed the OFC. The remaining 9 VL tolerant57) VL tolerant (n ¼ 32) VL reactive (n ¼ 25) p value*
15 (47) 17 (68) 0.111
17 (53) 8 (32)
15.0 (2.0e15.0)
(n ¼ 17)
7.0 (2.0e15.0)
(n ¼ 8)
0.031
28 (88) 23 (92) 0.461
3 (9.4) 6 (24) 0.128
13 (41) 17 (68) 0.040
0 (0.0) 2 (8.0) 0.188
10 (31) 16 (64) 0.014
nneWhitney test for continuous variables or the chi-square or Fisher's exact test for
Table 3
Symptoms and administered treatments during the very low-dose (VL) oral food
challenge with wheat.
VL reactive (n ¼ 25)
Symptoms
Skin (%) 18 (72)
Gastrointestinal (%) 7 (28)
Respiratory (%) 23 (92)
Cardiovascular (%) 1 (4.0)
Anaphylaxis (%) 13 (52)
Treatments
Antihistamine (%) 21 (84)
b2 agonist, nebulized (%) 23 (92)
Steroids (%) 6 (24)
Adrenaline (%) 3 (12)
The VL reactive subjects failed a VL oral food challenge conducted with 2 g of
udon noodles (equivalent to 53 mg of wheat protein).
Fig. 2. KaplaneMeier curves demonstrating the time required to achieve consumption
of 15 g of udon noodles (equivalent to 400 mg of wheat protein) during a 1-year period
after a very low-dose (VL) oral food challenge for wheat allergy.
Table 5
Comparisons of characteristics of previous allergic reactions to wheat between VL
tolerant subjects who reached a dose of 15 g of udon noodles (15 g tolerant) and VL
tolerant subjects who failed an OFC with 15 g of udon noodles (15 g reactive) within
1 year after the VL OFC.
Characteristic 15 g Tolerant
(n ¼ 18)
15 g Reactive
(n ¼ 6)
p value*
Reason for previous allergic reaction to wheat
Accidental ingestion 9 (50) 2 (33) 0.410
OFC with wheat 9 (50) 4 (67)
Threshold dose at previous OFC with
wheat (g udon noodles)
15.0 (6.0e15.0)
(n ¼ 9)
11.5 (2.0e15)
(n ¼ 4)
0.598
Symptom during previous allergic reaction to wheat
Skin 16 (89) 6 (100) 0.554
Gastrointestinal 3 (17) 0 (0) 0.403
Respiratory 4 (22) 5 (83) 0.015
Cardiovascular 0 (0) 0 (0)
Anaphylaxis 3 (17) 5 (83) 0.007
*Comparisons between 15 g tolerant and 15 g reactive subjects were conducted
using the ManneWhitney test for continuous variables or the chi-square or Fisher's
exact test for categorical variables. Statistically signiﬁcant p values (<0.05) are in
bold.
Values are reported as medians (ranges) or n (%).
OFC, oral food challenge.
Fifteen grams of udon noodles is equivalent to 400 mg of wheat protein.
Y. Okada et al. / Allergology International 65 (2016) 82e87 85subjects underwent gradual increases in their wheat doses at
home, and 1 reached a 15-g dose of udon noodles. Therefore, a total
of 18 (56%) VL tolerant subjects reached a dose of 15 g of udon
noodles.
Of the VL reactive subjects, only 2 of 16 who underwent a sec-
ond VL OFC passed this OFC. None (0.0%) of the VL reactive subjects
reached a dose of 15 g of udon noodles (p < 0.001) (Fig. 2).Table 4
Comparisons of baseline characteristics between VL tolerant subjects who reached a
dose of 15 g of udon noodles (15 g tolerant) and VL tolerant subjects who failed an
OFC with 15 g of udon noodles (15 g reactive) within 1 year after the VL OFC.
Characteristic 15 g Tolerant
(n ¼ 18)
15 g Reactive
(n ¼ 6)
p value*
Age (years) 2.0 (1.3e7.7) 5.6 (1.0e11.8) 0.317
Male sex 11 (61) 4 (67) 0.603
History of anaphylaxis to wheat 3 (17) 5 (83) 0.007
Other food allergy, current 14 (78) 5 (83) 0.634
Eczema, current 15 (83) 2 (33) 0.038
Asthma, current 4 (22) 3 (50) 0.215
Allergic rhino-conjunctivitis,
current
3 (17) 0 (0) 0.010
Total IgE (kUA/L) 329 (85.8e3050) 362 (141e1160) 0.947
Wheat-speciﬁc IgE (kUA/L) 19.1 (0.63e72.1) 17.3 (1.8e40.3) 0.947
u5-speciﬁc IgE (kUA/L) 0.70 (<0.10e11.9) 1.7 (0.15e5.67) 0.228
*Comparisons between 15 g tolerant and 15 g reactive subjects were conducted
using the ManneWhitney test for continuous variables or the chi-square or Fisher's
exact test for categorical variables. Statistically signiﬁcant p values (<0.05) are in
bold.
Values are reported as medians (ranges) or n (%).
IgE, immunoglobulin E; kUA/L, kilounits of allergen-speciﬁc IgE.
Fifteen grams of udon noodles is equivalent to 400 mg of wheat protein.When comparing the characteristics of VL tolerant subjects who
achieved a dose of 15 g of udon noodles (15 g tolerant, n ¼ 18) and
those of VL tolerant subjects who failed an OFC with 15 g of udon
noodles (15 g reactive, n ¼ 6), the 15 g tolerant and 15 g reactive
subjects showed signiﬁcant differences with regard to current
eczema, current allergic rhino-conjunctivitis, and a history of
respiratory symptoms and anaphylaxis in response to wheat
(Table 4, 5).
Adverse reaction to wheat consumed at home
A 2-year-old boy (3.1%) had 1 reactionary episode to 2 g of udon
noodles. The boy had an intermittent cough at 1 month after the VL
OFC. No subjects (0.0%) had any reactionary episodes to 3e15 g of
udon noodles. None of the adverse reactions required adrenaline or
a visit to the emergency department. There was no worsening of
eczema or asthma (Table 6).
Discussion
To the best of our knowledge, this is the ﬁrst study to indicate
that a VL OFC with wheat could be useful for the management of
low-dose reactive wheat-allergic children. Based on the OFCTable 6
Adverse reactions to wheat at home after passing the very low-dose (VL) oral food
challenge.
VL tolerant
Very low-dose
(2 g udon noodles)
(n ¼ 32)
Dose escalation
(3e15 g udon noodles)
(n ¼ 32)
No. (%) of subjects 1 (3.1) 0 (0.0)
No. of adverse reactions 1 0
Skin 0 0
Gastrointestinal 0 0
Respiratory 1 0
Cardiovascular 0 0
Anaphylaxis 0 0
The VL tolerant subjects passed a VL oral food challenge conducted with 2 g of udon
noodles (equivalent to 53 mg of wheat protein).
In this study, 3e15 g of udon noodles was equivalent to 80e400 mg of wheat
protein.
Y. Okada et al. / Allergology International 65 (2016) 82e8786results, half of the children in the present study could begin
consuming very low doses of wheat products on a daily basis.
Furthermore, approximately half of these VL-tolerant children
could consume 15 g of udon noodles within a year after the VL OFC.
We believe that our deﬁnition of low-dose reactivity to wheat is
appropriate because a previous study used 9 g of wheat ﬂour,
equivalent to 900 mg of wheat protein, for a low-dose OFC16; we
accordingly deﬁned low-dose reactive wheat allergy based on a
previous allergic reaction to <15 g of udon noodles, equivalent to
400 mg of wheat protein.
Wheat-speciﬁc andu5-speciﬁc IgE levels, respiratory symptoms
and anaphylaxis during a previous allergic reaction to wheat, and
the threshold dose of a previous OFC with wheat were found to be
predictors of VL OFC results, consistent with previous studies. Many
previous studies reported that wheat-speciﬁc and u5-speciﬁc IgE
levels were predictive of the outcome of an OFC with wheat.17e20
Nilsson et al. reported that respiratory symptoms during a previ-
ous allergic reaction were predictive of the results of an OFC with
wheat.20 Previous studies have not reported a predictive threshold
for a previous OFC with wheat. However, our ﬁndings are
compatible with those of our previous report, in which the
threshold dose of a previous OFC with cow's milk was predictive of
the results of a VL OFC with cow's milk.13
Although many of the VL reactive subjects experienced skin and
respiratory symptoms during the VL OFC, these reactions were
treatable with antihistamines and/or nebulized b2 agonists.
Compared with subjects who underwent an OFC with wheat in a
previous study, our subjects had higher levels of wheat-speciﬁc IgE
(median of subjects who failed the OFC in the present study,
42.2 kUA/L vs. 19.9 kUA/L in the earlier study) but a lower rate of
adrenaline treatment (12% vs. 18%).21 Because of the high anaphy-
laxis rate, our use of adrenaline may appear inappropriate. How-
ever, many respiratory symptoms were equivalent to mild
wheezing as deﬁned in the EAACI taskforce position paper,22 and
most reactions were mild to moderate, even in low-dose reactive
wheat-allergic children who failed the VL OFC.
Almost all VL tolerant subjects were able to safely consume less
than 15 g of udon noodles at home. Burks et al. reported that in a
placebo group, the adverse reaction rate was 3.9%.23 As even
placebos can cause adverse reactions to some extent, the adverse
reaction rate to 2 g of udon noodles at home (3.1%) can be
considered acceptable. Instead of a wheat OIT, low-dose reactive
wheat-allergic children can begin to consume wheat through a VL
OFC with wheat.
Compared with VL reactive subjects, VL tolerant subjects were
more likely to have reached a 15-g dose of udon noodles. Previous
studies reported that the wheat-speciﬁc IgE and u5-speciﬁc IgE
levels were predictive of the wheat allergy course.2,24 Whether the
VL OFC result is an independent predictor of the wheat allergy
course is not evident because of the potentially confounding dif-
ferences in wheat-speciﬁc IgE and u5-speciﬁc IgE levels in the
present study. However, Elizur et al. reported that a higher reaction
threshold predicted the resolution of an allergy to cow's milk.25
Therefore, the VL OFC result is a potential predictor of the wheat
allergy course.
VL tolerant subjects did not necessarily achieve a 15-g dose of
udon noodles. In the present study, current eczema, current allergic
rhino-conjunctivitis, and respiratory symptoms and anaphylaxis
during a previous allergic reaction to wheat were found to be
negative predictors of tolerance to a 15-g dose of udon noodles. VL
tolerant subjects with allergic comorbidities and/or a history of
respiratory symptoms and anaphylaxis in response towheat should
be carefully observed.
One limitation of our study is that it was not evident whether
the 8 VL tolerant subjects who underwent gradual increases in theirwheat doses at home but did not achieve a 15-g dose of udon
noodles, the 9 VL reactive subjects who did not undergo a second
VL OFC, and the other 2 VL reactive subjects who passed a second
VL OFC could ingest 15 g of udon noodles without any symptoms
within 1 year after the VL OFC. However, if we presume that the
same proportion of the 9 VL reactive subjects could have passed a
second VL OFC and the VL reactive subjects who passed a second VL
OFC could successfully ingest 15 g of udon noodles, the VL tolerant
subjects were still more likely than the VL reactive subjects to have
achieved tolerance to a 15-g dose of udon noodles.
In conclusion, VL OFC helps to identify low-dose reactive wheat-
allergic children who might be able to shift from complete avoid-
ance to partial intake of wheat, thus allowing better management.
Additional studies are needed to determine whether the VL OFC
result is predictive of the wheat allergy course.
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